Vitamin D receptor-binding site variants affect prostate cancer progression
Victor C. Lin(E-Da Hospital), Bo‐Ying Bao(Shanghai Jiao Tong University), Tsung-Yi Huang(Kaohsiung Medical University), Ta-Yuan Chang(China Medical University), Wen‐Lung Ma(Asia University), Chao‐Yuan Huang(Chung Shan Medical University), Hsin‐Ling Yin, Chia-Cheng Yu(National Yang Ming Chiao Tung University), Shu‐Pin Huang(Kaohsiung Medical University), Te‐Ling Lu(China Medical University), Cheng-Hsueh Lee(Kaohsiung Medical University), Huei‐Ju Ting(University of Rochester Medicine)
Cited by 13
Related Papers
Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma
|Gastroenterology|2008|253
Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor
|Hepatology|2008|207
Androgen Receptor Promotes Hepatitis B Virus–Induced Hepatocarcinogenesis Through Modulation of Hepatitis B Virus RNA Transcription
|Science Translational Medicine|2010|198
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
|eLife|2018|191
Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis
|Endocrine Related Cancer|2014|188